Guardant Health
GH
#1541
Rank
ยฃ10.06 B
Marketcap
ยฃ77.51
Share price
-0.92%
Change (1 day)
171.71%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of September 2025 : -ยฃ0.27 Billion

According to Guardant Health 's latest financial reports the company has -ยฃ0.27 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-ยฃ0.12 Billion-189.34%
2023-12-31$ยฃ0.12 B150.39%
2022-12-31$ยฃ49.74 M-89.59%
2021-12-31$ยฃ0.47 B-51.95%
2020-12-31$ยฃ0.99 B53.79%
2019-12-31$ยฃ0.64 B56.37%
2018-12-31$ยฃ0.41 B81.11%
2017-12-31$ยฃ0.22 B253.53%
2016-12-31$ยฃ64.58 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Natera
NTRA
ยฃ0.94 B-453.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
ยฃ1.59 B-697.69%๐Ÿ‡บ๐Ÿ‡ธ USA